Alzamend Neuro Stock Price on September 9, 2024
| ALZN Stock | USD 1.26 0.03 2.33% |
If you're considering investing in Alzamend Stock, it is important to understand the factors that can impact its price. As of today, the current price of Alzamend Neuro stands at 1.26, as last reported on the 27th of November, with the highest price reaching 1.30 and the lowest price hitting 1.26 during the day. Alzamend Neuro secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the company had a -0.23% return per unit of risk over the last 3 months. Alzamend Neuro exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alzamend Neuro's Mean Deviation of 2.98, standard deviation of 3.87, and Risk Adjusted Performance of (0.21) to double-check the risk estimate we provide.
As of the 27th of November 2024, Issuance Of Capital Stock is likely to grow to about 5.7 M, while Common Stock is likely to drop 65.55. . As of the 27th of November 2024, Price Earnings Ratio is likely to drop to -0.51. In addition to that, Price Book Value Ratio is likely to drop to -1.95. Alzamend Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Alzamend |
Sharpe Ratio = -0.2265
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALZN |
Estimated Market Risk
| 3.65 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.83 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Alzamend Neuro is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alzamend Neuro by adding Alzamend Neuro to a well-diversified portfolio.
Price Book 7.2255 | Book Value (1.41) | Enterprise Value 5.7 M | Enterprise Value Ebitda (3.13) | Shares Float 3.8 M |
Related Headline
TRACON Pharmaceuticals Headline on 28th of June 2024
TRACON Pharmaceuticals Downgraded to Hold at StockNews.com -... by news.google.com
TRACON Pharmaceuticals Downgraded to Hold at StockNews.com Defense World
Alzamend Neuro Valuation on September 9, 2024
It is possible to determine the worth of Alzamend Neuro on a given historical date. On September 9, 2024 Alzamend was worth 2.21 at the beginning of the trading date compared to the closed value of 2.09. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Alzamend Neuro stock. Still, in general, we apply an absolute valuation method to find Alzamend Neuro's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alzamend Neuro where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Alzamend Neuro's related companies.
| Open | High | Low | Close | Volume | |
| 2.18 | 2.27 | 2.05 | 2.12 | 452,513 | |
09/09/2024 | 2.21 | 2.25 | 2.04 | 2.09 | 366,687 |
| 2.12 | 2.14 | 1.99 | 2.11 | 300,300 |
| Backtest Alzamend Neuro | | | Alzamend Neuro History | | | Alzamend Neuro Valuation | Previous | Next |
Alzamend Neuro Trading Date Momentum on September 9, 2024
| On September 10 2024 Alzamend Neuro was traded for 2.11 at the closing time. The top price for the day was 2.14 and the lowest listed price was 1.99 . The trading volume for the day was 300.3 K. The trading history from September 10, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 0.96% . The overall trading delta against the current closing price is 15.79% . |
Alzamend Neuro Fundamentals Correlations and Trends
By evaluating Alzamend Neuro's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Alzamend Neuro's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Alzamend financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Alzamend Neuro Stock history
Alzamend Neuro investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alzamend is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alzamend Neuro will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alzamend Neuro stock prices may prove useful in developing a viable investing in Alzamend Neuro
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 676.6 K | 642.7 K | |
| Net Loss | -13.4 M | -12.7 M |
Alzamend Neuro Stock Technical Analysis
Alzamend Neuro technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Alzamend Neuro Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Alzamend Neuro cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Alzamend Neuro November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Alzamend Neuro stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alzamend Neuro shares will generate the highest return on investment. By undertsting and applying Alzamend Neuro stock market strength indicators, traders can identify Alzamend Neuro entry and exit signals to maximize returns
Alzamend Neuro Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Alzamend Neuro's price direction in advance. Along with the technical and fundamental analysis of Alzamend Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alzamend to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.21) | |||
| Jensen Alpha | (1.10) | |||
| Total Risk Alpha | (1.74) | |||
| Treynor Ratio | 5.45 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alzamend Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (142.87) | Return On Assets (2.14) | Return On Equity (44.08) |
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.